Why I’ve Bought Chemring Group Plc

Chemring Group plc (LON:CHG) is the cheapest company in the defence sector.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As stock markets globally have risen, contrarians seeking out cheap shares, myself included, have found fewer bargains. However, defence company Chemring (LSE: CHG) recently caught my attention.

This company’s share price has been what investors term a ‘falling knife’. Since its peak in 2010 the share price has been tumbling lower and lower after a succession of disappointing results. Last month’s numbers sent Chemring’s shares even lower. In simple terms, the share price is now less than a third of its all-time high.

No company grows forever

At some point, the growth rate of a company that has been booming suddenly slows. When this happens, the market reassesses its view of this company, and often the share price crashes as the company is re-rated. Examples in the recent past of this include car insurance company Admiral and satellite company Inmarsat.

This is basically the market adjusting to reality, as no company grows forever. That’s what you always have to be wary of in-growth companies — after all, no tree grows to the sky. At some point, the growth ends.

But when the share price crashes, often there is too much pessimism. The value of the company crashes further and faster than anyone expects. The fear is that the share price will eventually fall to zero. But if the company is fundamentally strong, and its earnings are steady, the share price will actually recover.

So those who buy at the time of the crash can actually make a tidy profit. This is, as John Templeton called it, ‘the time of maximum pessimism’. How can you judge this? Well, it’s not easy, but I typically look for a discrepancy between the negative sentiment and the predicted performance of the company.

A growth company which has turned into an income investment

This is what I now see for Chemring. It is now rated on a P/E ratio of just 10, which is predicted to be steady in future years — this looks cheap to me, plus there is a juicy dividend yield. Yet the share price has been crashing through the floor.

This is a defence company, and admittedly defence is not a growth sector. But take BAE Systems: last year this was also an unloved, unwanted defence stock. But many canny investors, including Neil Woodford, invested in the company. It turned out to be an astute buy, rocketing over the past year and substantially out-performing the wider market.

This is the art of contrarian investing — it might sound easy, but it is actually really difficult. That’s why most investors can’t beat the market. That’s why the world has only one Warren Buffett.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Prabhat owns shares in Chemring.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »